Sort
53,477 grants matching “addiction”
Integrative Predictors of Temporomandibular Degenerative Joint Disease
$698,865Lucia H Cevidanes · Univ Of North Carolina Chapel Hill · R01 · FY2025 · DE
Structural Basis of Signal Instigation Through Family C GPCRs
$698,575Georgios Skiniotis · St. Jude Children'S Research Hospital · R01 · FY2025 · NS
Signal Transduction by Tyrosine Phosphorylation
$698,480Tony R. Hunter · Salk Institute For Biological Studies · R01 · FY2010 · CA
Behavioral Phenotyping Core
$698,478Leona Gagnon · Jackson Laboratory · P50 · FY2025 · DA
Examining opioid use disorder treatment in Medicaid managed care plans: policies and outcomes
$698,453Maureen T Stewart · Brandeis University · R01 · FY2021 · DA
TREATING COCAINE ABUSE: A BEHAVIORAL APPROACH
$698,421University Of Vermont &St Agric College · R37 · FY2004 · DA
Addiction Telemedicine Consultation in Primary Care: Increasing Access to Pharmacotherapy and Specialty Treatment for Alcohol Problems
$698,415Stacy Ann Sterling · Kaiser Foundation Research Institute · R01 · FY2021 · AA
Addiction Telemedicine Consultation in Primary Care: Increasing Access to Pharmacotherapy and Specialty Treatment for Alcohol Problems
$698,415Stacy Ann Sterling · Kaiser Foundation Research Institute · R01 · FY2022 · AA
Impact of the COVID-19 pandemic on patient outcomes, telehealth care delivery, and treatment for unhealthy alcohol use in vulnerable patients with advanced liver disease across two healthcare systems
$698,400Mandana Khalili · University Of California, San Francisco · R01 · FY2024 · AA
Neurobehavioral consequences of Mild Traumatic Brain Injury and addiction risk: a cotwin-control study
$698,292Andrey P. Anokhin · Washington University · R01 · FY2023 · DA
Structural basis of nicotinic acetylcholine receptor gating and toxin inhibition
$698,278Ryan E Hibbs · University Of California, San Diego · R01 · FY2023 · NS
Dissecting the Synaptic and Cellular Actions of Dopamine in Vivo
$698,220Tanya Sippy · New York University School Of Medicine · R01 · FY2024 · MH
Dissecting the Synaptic and Cellular Actions of Dopamine in Vivo
$698,220Tanya Sippy · New York University School Of Medicine · R01 · FY2025 · MH
Dissecting the Synaptic and Cellular Actions of Dopamine in Vivo
$698,220Tanya Sippy · New York University School Of Medicine · R01 · FY2023 · MH
Peer Influence and Selection Mechanisms Underlying Adolescent Problem Behaviors
$698,201Julie C Rusby · Oregon Research Institute · R01 · FY2013 · DA
Mindfulness-Based Relapse Prevention: Efficacy and Mechanisms
$698,195Sarah Bowen · University Of Washington · R01 · FY2010 · DA
Preclinical optimization of a gene therapy for erythromelalgia and chronic pain
$698,171Fernando Aleman Guillen · Navega Therapeutics, Inc. · U44 · FY2021 · NS
Impact on opioid use of bundling medication-assisted treatment with mHealth
$698,163David H Gustafson · University Of Wisconsin-Madison · R01 · FY2016 · DA
Epigenetic Drivers of Cancer (PQ 10)
$698,103Peter W Laird · Van Andel Research Institute · R01 · FY2015 · CA
Neurophysiology underlying neural representations of value
$698,101C. Daniel Salzman · Columbia University Health Sciences · R01 · FY2020 · MH
Enhancing Substance Use Treatment Services to Decrease Dropout and Improve Outpatient Treatment Utilization in Emerging Adults
$698,002Kristyn Zajac · University Of Connecticut Sch Of Med/Dnt · R01 · FY2025 · DA
Ending the HIV Epidemic: Peer-supported collaborative care for mental health and substance use disorder care integration into HIV care settings
$697,934Oluwaseun Falade-Nwulia · Johns Hopkins University · R01 · FY2023 · DA
A randomized trial of urban vacant lot stabilization and substance abuse outcomes
$697,881Daniel E Polsky · University Of Pennsylvania · R01 · FY2015 · AA
Clinical Trial of Topiramate for Cocaine Addiction
$697,877Annie Umbricht · Johns Hopkins University · R01 · FY2009 · DA
Implementation, Outcomes, and Cost of a Novel Medicaid Policy to Reduce Opioids for Back Pain
$697,803Esther K Choo · Oregon Health & Science University · R01 · FY2018 · DA